<DOC>
	<DOCNO>NCT00251277</DOCNO>
	<brief_summary>The purpose evaluate safety feasibility use Rituximab adjunct standard therapy ( plasmapheresis + steroid ) patient thrombotic thrombocytopenic purpura ( TTP ) . This include evaluate rate type treatment failure .</brief_summary>
	<brief_title>Use Rituximab Treatment Addition Standard Care Newly Presenting Thrombotic Thrombocytopenic Purpura</brief_title>
	<detailed_description>With study hope evaluate safety feasibility use Rituximab adjunct standard therapy ( plasmapheresis + steroid ) patient thrombotic thrombocytopenic purpura ( TTP ) . This include evaluate rate type treatment failure .</detailed_description>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombotic Thrombocytopenic</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Patients include trial base follow criterion : Patients must TTP platelet count &lt; 100,000/mL microangiopathic hemolytic anemia define presence 310 fragment red blood cell ( schistocytes ) per high power file peripheral blood smear . Either gender , age 17 old Men woman reproductive potential must agree use acceptable method birth control treatment six month completion treatment . TTP related underlying cancer , treatment cancer transplantation New onset TTP , previously diagnose TTP unmaintained remission &gt; 12 month . LDH &gt; 2X upper limit normal Prothrombin time ( PT ) , partial thromboplastin time ( PTT ) normal Direct antiglobulin test ( DAT ) negative Subject provide write informed consent Patients receive 3 plasmapheresis . Patients exclude trial base follow criterion : A diagnosis AIDS . Patients HIV infection absolute CD4 count &gt; 200/ul active , significant opportunistic infection eligible Patients know hepatitis C infection ( HCV ) and/or hepatitis B Patients receive pheresis day Recent ( within 1 year ) bone marrow hematopoietic stem cell transplant Patient calcineurin inhibitor , unable come Acute chronic disseminate intravascular coagulation ( DIC ) , define Ddimers &gt; 8mg/ml fibrinogen &lt; 100 mg ( 0.1g ) /dl A diagnosis metastatic nonmetastatic malignancy basal cell carcinoma . Malignant hypertension ( systolic blood pressure [ BP ] &gt; 200 mm Hg diastolic BP &gt; 130 mm Hg ) Pregnancy ( negative serum pregnancy test perform woman childbearing potential within 7 day treatment ) . Eligibility resume 3 day delivery Patients family history previous diagnosis congenital TTP Patients hemolytic uremic syndrome ( HUS ) Patients sepsis</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Thrombotic Thrombocytopenic Purpura</keyword>
	<keyword>TTP</keyword>
	<keyword>Hematology</keyword>
</DOC>